As of 2025-07-08, the Intrinsic Value of Phapros Tbk PT (PEHA.JK) is (7,387.64) IDR. This PEHA.JK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 320.00 IDR, the upside of Phapros Tbk PT is -2,408.60%.
The range of the Intrinsic Value is (13,550.38) - (5,385.75) IDR
Based on its market price of 320.00 IDR and our intrinsic valuation, Phapros Tbk PT (PEHA.JK) is overvalued by 2,408.60%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (13,550.38) - (5,385.75) | (7,387.64) | -2408.6% |
| DCF (Growth 10y) | (4,996.87) - (11,250.95) | (6,539.29) | -2143.5% |
| DCF (EBITDA 5y) | (2,937.51) - (3,143.56) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (3,219.99) - (3,461.32) | (1,234.50) | -123450.0% |
| Fair Value | -1,555.82 - -1,555.82 | -1,555.82 | -586.19% |
| P/E | (3,385.45) - (4,325.17) | (3,601.71) | -1225.5% |
| EV/EBITDA | (2,105.33) - (2,201.91) | (2,099.58) | -756.1% |
| EPV | (927.16) - (946.72) | (936.94) | -392.8% |
| DDM - Stable | (1,449.96) - (3,510.87) | (2,480.42) | -875.1% |
| DDM - Multi | (1,141.43) - (2,267.01) | (1,530.01) | -578.1% |
| Market Cap (mil) | 268,800.00 |
| Beta | 0.91 |
| Outstanding shares (mil) | 840.00 |
| Enterprise Value (mil) | 955,622.00 |
| Market risk premium | 7.88% |
| Cost of Equity | 15.50% |
| Cost of Debt | 5.00% |
| WACC | 7.10% |